TY  - JOUR

T1  - Mesenchymal intravenous stromal cell infusions in children with recessive dystrophic epidermolysis bullosa: MissionEB protocol for a randomised, double-blinded, placebo-controlled, two-centre, crossover trial with an internal phase I dose de-escalation phase and open-label extension

JO  - BMJ Open

UR  - https://doi.org/10.1136/bmjopen-2024-089857

PY  - 2025/05/21

AU  - Bageta ML

AU  - López-Balboa P

AU  - Dimairo M

AU  - Glover R

AU  - Hutchence K

AU  - Papaioannou D

AU  - Cooper C

AU  - Biggs K

AU  - Tappenden P

AU  - Ennis K

AU  - Ogboli M et al

ED  - 

DO  - DOI: 10.1136/bmjopen-2024-089857

PB  - BMJ

VL  - 15

IS  - 5

SP  - e089857

EP  - e089857

Y2  - 2025/06/04

ER  -